2008Shiyong yixue zazhiRequires access

Evaluation of multiple tumor marker protein biochip detective system in diagnosis of lung cancer

Cao Zheng-hua

Open publisher page 0 citations

Abstract

Objective To explore the clinical application value of multiple tumor marker protein biochip detective system in diagnosis of lung cancer. Methods Serum levels of twelve tumor markers such as CA19-9, NSE, CEA, CA242, CA125, CA153, AFP, ferritin, f-PSA, PSA, β-HCG and HGH in 276 healthy volunteers and 254 pathologically or cytological diagnosed lung cancer patients were measured and analysed with a C-12 multiple tumor marker protein biochip detective system respectively. Results The positive rate of the C-12 multiple tumor marker proteins in lung cancer group was significantly higher than that of healthy volunteers group (68.90% vs 17.03%, χ2 = 152.95, P 0.01), the sensitivity and specificity was 68.9% and 82.9% respectively. The positive rates of ferritin, CA125, CEA and CA19-9 were 41.04%, 35.86%, 33.47% and 13.15% respectively in lung cancer group. Conclusion C-12 multiple tumor marker protein biochip detective system has relatively high practical application value in the diagnosis of lung cancer.

About this research paper

What this paper is about

Objective To explore the clinical application value of multiple tumor marker protein biochip detective system in diagnosis of lung cancer. Methods Serum levels of twelve tumor markers such as CA19-9, NSE, CEA, CA242, CA125, CA153, AFP, ferritin, f-PSA, PSA, β-HCG and HGH in 276 healthy volunteers and 254 pathologically or cytological diagnosed lung cancer patients were measured and analysed with a C-12 multiple tumor marker protein biochip detective system respectively. Results The positive rate of the C-12 multiple tumor marker proteins in lung cancer group was significantly higher than that of healthy volunteers group (68.90% vs 17.03%, χ2 = 152.95, P 0.01), the sensitivity and specificity was 68.9% and 82.9% respectively. The positive rates of ferritin, CA125, CEA and CA19-9 were 41.04%, 35.86%, 33.47% and 13.15% respectively in lung cancer group. Conclusion C-12 multiple tumor marker protein biochip detective system has relatively high practical application value in the diagnosis of lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical application value of multiple tumor marker protein biochip detective system in diagnosis of lung cancer. Methods Serum levels of twelve tumor markers such as CA19-9, NSE, CEA, CA242, CA125, CA153, AFP, ferritin, f-PSA, PSA, β-HCG and HGH in 276 healthy volunteers and 254 pathologically or cytological diagnosed lung cancer patients were measured and analysed with a C-12 multiple tumor marker protein biochip detective system respectively. Results The positive rate of the C-12 multiple tumor marker proteins in lung cancer group was significantly higher than that of healthy volunteers group (68.90% vs 17.03%, χ2 = 152.95, P 0.01), the sensitivity and specificity was 68.9% and 82.9% respectively. The positive rates of ferritin, CA125, CEA and CA19-9 were 41.04%, 35.86%, 33.47% and 13.15% respectively in lung cancer group. Conclusion C-12 multiple tumor marker protein biochip detective system has relatively high practical application value in the diagnosis of lung cancer.

Key concepts: Lung cancer, Tumor marker, Ferritin, Biochip, Protein chip, Medicine, Lung, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of multiple tumor marker protein biochip detective system in diagnosis of lung cancer — Research Paper | ScholarLens